Atenolol and Timolol
- 18 November 1982
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 307 (21), 1343-1346
- https://doi.org/10.1056/nejm198211183072116
Abstract
To the Editor: In a recent review of two β-blockers released for clinical use in the United States (June 17 issue) Frishman discusses the use of atenolol in treating hypertension.1 One side effect not mentioned in the review is the induction of lipoprotein abnormalities during β-blockade. The general pattern in most studies seems to be an increase in the concentration of very-low-density lipoproteins and a decrease in the concentration of high-density lipoproteins during β-blockade.2 Hyperlipoproteinemia is common in patients with hypertension, and an incidence of up to 40 per cent — twice as high as in controls — has . . .Keywords
This publication has 16 references indexed in Scilit:
- Atenolol and Timolol, Two New Systemic β-Adrenoceptor AntagonistsNew England Journal of Medicine, 1982
- β-Adrenoceptor Antagonists: New Drugs and New IndicationsNew England Journal of Medicine, 1981
- Relative activities of atenolol and metoprolol on the cardiovascular system of manEuropean Journal of Clinical Pharmacology, 1981
- Serum lipoprotein changes during atenolol treatment of essential hypertensionEuropean Journal of Clinical Pharmacology, 1981
- THE EFFECT OF ATENOLOL ON SERUM THYROID HORMONES IN HYPERTHYROID PATIENTSClinical Endocrinology, 1980
- Propranolol therapy in thyrotoxicosisAmerican Journal Of Medicine, 1979
- Non‐Selective and Selective β‐1‐Adrenoceptor Blocking Agents in the Treatment of HyperthyroidismActa Medica Scandinavica, 1979
- TimololDrugs, 1979
- Comparative trial of atenolol and propranolol in hyperthyroidism.British Journal of Clinical Pharmacology, 1978
- Hypertension and raised serum lipids.BMJ, 1977